Heike Lindenmaier

874 total citations
11 papers, 734 citations indexed

About

Heike Lindenmaier is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Heike Lindenmaier has authored 11 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pediatrics, Perinatology and Child Health and 2 papers in Infectious Diseases. Recurrent topics in Heike Lindenmaier's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and HIV/AIDS drug development and treatment (2 papers). Heike Lindenmaier is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and HIV/AIDS drug development and treatment (2 papers). Heike Lindenmaier collaborates with scholars based in Germany and United States. Heike Lindenmaier's co-authors include Walter E. Haefeli, Johanna Weiß, Dirk Theile, Caroline Henrike Storch, Nahal Ketabi‐Kiyanvash, Tanja Peters, Kirsten Vang Nielsen, Manfred Hergenhahn, Petra Boukamp and Michael J. Thomas and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and European Respiratory Journal.

In The Last Decade

Heike Lindenmaier

11 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heike Lindenmaier Germany 10 397 229 187 173 84 11 734
Christopher Matheny United States 12 356 0.9× 139 0.6× 86 0.5× 109 0.6× 73 0.9× 23 695
Niresh Hariparsad United States 18 355 0.9× 194 0.8× 189 1.0× 194 1.1× 27 0.3× 37 974
Jason M. Gow United States 11 266 0.7× 140 0.6× 92 0.5× 157 0.9× 28 0.3× 12 615
Sarah Shugarts United States 9 259 0.7× 119 0.5× 76 0.4× 130 0.8× 60 0.7× 13 691
Marina Kacevska Australia 14 384 1.0× 160 0.7× 56 0.3× 364 2.1× 36 0.4× 14 1.2k
Yuichi Sugiyama Japan 13 700 1.8× 362 1.6× 89 0.5× 249 1.4× 18 0.2× 21 951
Jonathan Q. Tran United States 19 136 0.3× 64 0.3× 170 0.9× 287 1.7× 23 0.3× 43 1.0k
Cheryl D. Cropp United States 15 186 0.5× 127 0.6× 50 0.3× 139 0.8× 65 0.8× 29 599
Sierk Haenisch Germany 23 829 2.1× 491 2.1× 158 0.8× 440 2.5× 40 0.5× 30 1.4k
Masaya Itoda Japan 13 657 1.7× 296 1.3× 137 0.7× 249 1.4× 34 0.4× 17 945

Countries citing papers authored by Heike Lindenmaier

Since Specialization
Citations

This map shows the geographic impact of Heike Lindenmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Lindenmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Lindenmaier more than expected).

Fields of papers citing papers by Heike Lindenmaier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Lindenmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Lindenmaier. The network helps show where Heike Lindenmaier may publish in the future.

Co-authorship network of co-authors of Heike Lindenmaier

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Lindenmaier. A scholar is included among the top collaborators of Heike Lindenmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Lindenmaier. Heike Lindenmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Warth, Arne, Roland Penzel, Heike Lindenmaier, et al.. (2013). EGFR,KRAS,BRAFandALKgene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. European Respiratory Journal. 43(3). 872–883. 93 indexed citations
2.
Storch, Caroline Henrike, Dirk Theile, Heike Lindenmaier, Walter E. Haefeli, & Johanna Weiß. (2007). Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. Biochemical Pharmacology. 73(10). 1573–1581. 131 indexed citations
3.
Weiß, Johanna, Dirk Theile, Nahal Ketabi‐Kiyanvash, Heike Lindenmaier, & Walter E. Haefeli. (2006). Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors. Drug Metabolism and Disposition. 35(3). 340–344. 108 indexed citations
4.
Peters, Tanja, Heike Lindenmaier, Walter E. Haefeli, & Johanna Weiß. (2005). Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein. Naunyn-Schmiedeberg s Archives of Pharmacology. 372(4). 291–299. 64 indexed citations
5.
Lindenmaier, Heike, et al.. (2005). INTERACTION OF PROGESTINS WITH THE HUMAN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2). Drug Metabolism and Disposition. 33(11). 1576–1579. 28 indexed citations
6.
Rengelshausen, Jens, Heike Lindenmaier, Tomáš Cihlář, et al.. (2004). Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine. Biochemical and Biophysical Research Communications. 320(1). 90–94. 9 indexed citations
7.
Martin‐Facklam, Meret, Jens Rengelshausen, Yorki Tayrouz, et al.. (2004). Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?. European Journal of Clinical Pharmacology. 60(11). 807–811. 24 indexed citations
8.
Lindenmaier, Heike, et al.. (2004). Modulation of Cellular Cholesterol Alters P-Glycoprotein Activity in Multidrug-Resistant Cells. Molecular Pharmacology. 66(5). 1332–1339. 96 indexed citations
9.
Weiß, Johanna, et al.. (2003). Interaction of Antiepileptic Drugs with Human P-Glycoprotein in Vitro. Journal of Pharmacology and Experimental Therapeutics. 307(1). 262–267. 104 indexed citations
10.
Lindenmaier, Heike, et al.. (2003). Influence of lipid lowering fibrates on P-glycoprotein activity in vitro. Biochemical Pharmacology. 67(2). 285–292. 31 indexed citations
11.
Lindenmaier, Heike, et al.. (2000). Telomere erosion varies during in vitro aging of normal human fibroblasts from young and adult donors.. PubMed. 60(11). 2770–4. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Matheny Breakdown of academic impact, for papers by Niresh Hariparsad Breakdown of academic impact, for papers by Jason M. Gow Breakdown of academic impact, for papers by Sarah Shugarts Breakdown of academic impact, for papers by Marina Kacevska Breakdown of academic impact, for papers by Yuichi Sugiyama Breakdown of academic impact, for papers by Jonathan Q. Tran Breakdown of academic impact, for papers by Cheryl D. Cropp Breakdown of academic impact, for papers by Sierk Haenisch Breakdown of academic impact, for papers by Masaya Itoda
Rankless by CCL
2026